In today’s world, power is no longer defined solely by military might or economic clout. It is increasingly shaped by a country’s ability to harness, diffuse, and govern technology. In a recent essay, renowned public intellectual Pratap Bhanu Mehta offers a powerful insight into how technology reshapes the global balance of power — and why India needs to rethink its strategy if it wishes to emerge as a genuine technology leader. Rather than obsessing over sectoral dominance — whether in artificial intelligence (AI), semiconductors, or quantum computing — Mehta argues that India should focus on fostering an ecosystem that enables the diffusion of General Purpose Technologies (GPTs) . These are technologies that do not merely transform single industries but instead spark cascading changes across the entire economy and society. The idea is both simple and radical: power in the 21st century is not about who owns a particular technology but about who enables its widespread and inclusive...
In recent years, the biotech industry has emerged as a cornerstone of innovation, especially in areas like gene therapy , personalized medicine , and vaccine development . However, this dynamic and promising sector is highly sensitive to government regulations , policy frameworks , and economic signals . Under the Trump administration , the biotech sector witnessed a turbulent journey, driven by policy uncertainty , sudden regulatory shifts, and volatile rhetoric on healthcare pricing reforms . This blog delves into how Trump’s policy ambiguity and decision-making style impacted the biotech industry, contributing to a market slump and investor hesitancy. It also analyzes the broader implications for pharmaceutical innovation , R&D funding , and global biotech partnerships . Trump Administration and Policy Volatility One of the defining features of Donald Trump’s presidency was his unconventional approach to governance . For sectors like biotech, which rely on predictable and ...